Prediction of estrogen receptor β ligands potency and selectivity by docking and MM-GBSA scoring methods using three different scaffolds

This study aimed to identify the docking and molecular mechanics-generalized born surface area (MM-GBSA) re-scoring parameters which can correlate the binding affinity and selectivity of the ligands towards oestrogen receptor β (ERβ). Three different series of ERβ ligands were used as dataset and the compounds were docked against ERβ (protein data bank (PDB) ID: 1QKM) using Glide and ArgusLab. Glide docking showed superior results when compared with ArgusLab. Docked poses were then rescored using Prime-MM-GBSA to calculate free energy binding. Correlations were made between observed activities of ERβ ligands with computationally predicted values from docking, binding energy parameters. ERβ ligands experimental binding affinity/selectivity did not correlate well with Glide and ArgusLab score. Whereas calculated Glide energy (coulomb-van der Waal interaction energy) correlated significantly with binding affinity of ERβ ligands (r2 = 0.66). MM-GBSA re-scoring showed correlation of r2 = 0.74 with selectivity of ERβ ligands. These results will aid the discovery of novel ERβ ligands with isoform selectivity.

[1]  Julian Tirado-Rives,et al.  Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding. , 2006, Journal of medicinal chemistry.

[2]  Robert W. Hsieh,et al.  Identification of Ligands with Bicyclic Scaffolds Provides Insights into Mechanisms of Estrogen Receptor Subtype Selectivity* , 2006, Journal of Biological Chemistry.

[3]  Brian K Shoichet,et al.  Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. , 2006, Journal of medicinal chemistry.

[4]  Cristiano Ruch Werneck Guimarães,et al.  MM-GB/SA Rescoring of Docking Poses in Structure-Based Lead Optimization , 2008, J. Chem. Inf. Model..

[5]  M. Gilson,et al.  Calculation of protein-ligand binding affinities. , 2007, Annual review of biophysics and biomolecular structure.

[6]  J. Katzenellenbogen,et al.  Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes. , 2006, Journal of medicinal chemistry.

[7]  Cristiano Ruch Werneck Guimarães,et al.  Addressing Limitations with the MM-GB/SA Scoring Procedure using the WaterMap Method and Free Energy Perturbation Calculations , 2010, J. Chem. Inf. Model..

[8]  Weihua Li,et al.  Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening. , 2010, Journal of medicinal chemistry.

[9]  G. de Fabritiis,et al.  Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations , 2011, Proceedings of the National Academy of Sciences.

[10]  Eric S Manas,et al.  ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives. , 2004, Bioorganic & medicinal chemistry.

[11]  Samuel Genheden,et al.  Binding Affinities of Factor Xa Inhibitors Estimated by Thermodynamic Integration and MM/GBSA , 2011, J. Chem. Inf. Model..

[12]  David H. Kaufman,et al.  7-Substituted 2-phenyl-benzofurans as ERβ selective ligands , 2004 .

[13]  Francesco Luigi Gervasio,et al.  Free-energy-based methods for binding profile determination in a congeneric series of CDK2 inhibitors. , 2010, The journal of physical chemistry. B.

[14]  Eric S Manas,et al.  ERβ Ligands. Part 1: The discovery of ERβ selective ligands which embrace the 4-hydroxy-biphenyl template , 2003 .

[15]  Margaret Warner,et al.  Estrogen receptors: how do they signal and what are their targets. , 2007, Physiological reviews.

[16]  M Carlquist,et al.  Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.

[17]  B Coupez,et al.  Docking and scoring--theoretically easy, practically impossible? , 2006, Current medicinal chemistry.

[18]  Paul D Lyne,et al.  Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. , 2006, Journal of medicinal chemistry.